Table 1 Baseline demographic, disease, and clinical characteristics
Variable | General (N = 340) | Antibody Group(N = 170) | Control Group (N = 170) | P value |
|---|---|---|---|---|
Age(years old) | 72.0(58.0, 81.0) | 75.0(63.8, 83.3) | 70.0(53.8, 78.0) | <0.001 |
Sex, male(n,%) | 206, 60.6 | 111, 65.3 | 95, 55.9 | 0.076 |
Severe type rate(n,%) | 69, 20.3 | 40, 23.5 | 29, 17.1 | 0.138 |
Comorbidity(n,%) | ||||
COPD | 73, 21.5 | 42, 24.7 | 31, 18.2 | 0.146 |
Lung cancer | 8, 2.4 | 5, 2.9 | 3, 1.8 | 0.723 |
CHD | 70, 20.6 | 40, 23.5 | 30, 17.6 | 0.180 |
Hypertension | 138, 40.6 | 74, 43.5 | 64, 37.6 | 0.269 |
DM | 74, 21.8 | 35, 20.6 | 39, 22.9 | 0.599 |
CKD | 19, 5.6 | 14, 8.2 | 5, 2.9 | 0.034 |
None | 50, 14.7 | 19, 11.2 | 31, 18.2 | 0.066 |
Using immunoglobulins(n,%) | 20, 5.9 | 9, 5.3 | 11, 6.5 | 0.645 |
Using Azvudine or Paxlovid (n,%) | 216, 63.5 | 115, 67.6 | 101, 59.4 | 0.115 |